These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15215557)

  • 1. New generation of valproic acid.
    Trojnar MK; Wierzchowska-Cioch E; Krzyzanowski M; Jargiełło M; Czuczwar SJ
    Pol J Pharmacol; 2004; 56(3):283-8. PubMed ID: 15215557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?
    Isoherranen N; Yagen B; Bialer M
    Curr Opin Neurol; 2003 Apr; 16(2):203-11. PubMed ID: 12644750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic analysis of (E)-2-ene valproyl derivatives of glycine and valproyl derivatives of nipecotic acid.
    Bialer M; Kadry B; Abdul-Hai A; Haj-Yehia A; Sterling J; Herzig Y; Shirvan M
    Biopharm Drug Dispos; 1996 Oct; 17(7):565-75. PubMed ID: 8894115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: evaluation of the teratogenic effects of its amide derivatives in NMRI mice.
    Okada A; Onishi Y; Yagen B; Shimshoni JA; Kaufmann D; Bialer M; Fujiwara M
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):610-21. PubMed ID: 18671279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of antiepileptic tetramethylcyclopropyl analogues of valproic acid amides in a rat model of neuropathic pain.
    Winkler I; Sobol E; Yagen B; Steinman A; Devor M; Bialer M
    Neuropharmacology; 2005 Dec; 49(8):1110-20. PubMed ID: 16055160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatment of epilepsy in elderly people: focus on valproic Acid.
    Stephen LJ
    Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats.
    Blotnik S; Bergman F; Bialer M
    Drug Metab Dispos; 1996 May; 24(5):560-4. PubMed ID: 8723737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antiepileptic drugs that are second generation to existing antiepileptic drugs.
    Bialer M
    Expert Opin Investig Drugs; 2006 Jun; 15(6):637-47. PubMed ID: 16732716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant profile and teratogenicity of 3,3-dimethylbutanoylurea: a potential for a second generation drug to valproic acid.
    Shimshoni JA; Yagen B; Pessah N; Wlodarczyk B; Finnell RH; Bialer M
    Epilepsia; 2008 Jul; 49(7):1202-12. PubMed ID: 18435754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent anticonvulsant urea derivatives of constitutional isomers of valproic acid.
    Shimshoni JA; Bialer M; Wlodarczyk B; Finnell RH; Yagen B
    J Med Chem; 2007 Dec; 50(25):6419-27. PubMed ID: 17994680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic Acid: second generation.
    Bialer M; Yagen B
    Neurotherapeutics; 2007 Jan; 4(1):130-7. PubMed ID: 17199028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of treatment and selection of antiepileptic drugs in childhood epilepsy.
    Oka E; Murakami N; Ogino T; Kobayashi K; Ohmori I; Akiyama T; Ito M
    Epilepsia; 2004; 45 Suppl 8():17-9. PubMed ID: 15610189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues.
    Kaufmann D; Bialer M; Shimshoni JA; Devor M; Yagen B
    J Med Chem; 2009 Nov; 52(22):7236-48. PubMed ID: 19877649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain.
    Winkler I; Blotnik S; Shimshoni J; Yagen B; Devor M; Bialer M
    Br J Pharmacol; 2005 Sep; 146(2):198-208. PubMed ID: 15997234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function studies for the panacea, valproic acid.
    Terbach N; Williams RS
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1126-32. PubMed ID: 19754465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant activity, neural tube defect induction, mutagenicity and pharmacokinetics of a new potent antiepileptic drug, N-methoxy-2,2,3,3-tetramethylcyclopropane carboxamide.
    Sobol E; Yagen B; Lamb JG; White HS; Wlodarczyk BJ; Finnell RH; Bialer M
    Epilepsy Res; 2007 Jan; 73(1):75-84. PubMed ID: 16997532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician.
    Dutta S; Reed RC
    J Clin Pharm Ther; 2006 Aug; 31(4):321-9. PubMed ID: 16882100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DP-VPA D-Pharm.
    Labiner DM
    Curr Opin Investig Drugs; 2002 Jun; 3(6):921-3. PubMed ID: 12137414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profiles of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis.
    Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2006 Nov; 47(11):1841-54. PubMed ID: 17116023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.